US4030977A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for purification of physiologically active substance using enzyme-enzyme inhibitor system
Assignee: Ono Pharmaceutical Co Ltd
•
Filing: 1976-03-19
•
Granted: 1977-06-21
•
Expires: 1996-03-19
Abstract
Abstract A method for isolating and purifying a physiologically active substance contained in a tissue or a body fluid using an insoluble type naturally occurring proteolytic enzyme inhibitor or an insoluble type proteolytic enzyme alone or in combination with the insoluble type naturally occurring proteolytic enzyme inhibitor is disclosed.
Inventors
- 👤 Setsuro Fujii
- 👤 Yasumichi Kajita
- 👤 Seizi Hiraku
- 👤 Heizo Kira
- 👤 Hideki Aishita
- 👤 Keiko Muryobayashi
- 👤 Hiroshi Terashima
- 👤 Akira Akimoto
- 👤 Ken Taniguchi
- 👤 Minoru Wada
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 14:08
CPC Classifications
C; C12; C12N; C12N11/00; C12N11/02; C12N9/00
Claims Analysis
Total Claims: 5
Claim 1
Independent Claim
135 words
A method for isolating and purifying kallikrein contained in mammalian tissue or body fluid which comprises contacting an extract of said tissue or said body fluid with a material formed of an insoluble carrier chemically coupled to a proteolytic enzyme inhibitor for kallekrein, said material being selected from an insolubilized naturally occurring enzyme inhibitor so as to bind said kallikrein and eluting said kallikrein therefrom using first 0.1 M acetate buffer of pH 4.0 and second 0.1 N acetic acid solution and immediately adding the eluate drop-wise to 2M Tris-amino-methane HCl buffer of pH 8.0 to 10.0, wherein said process is carried out by contacting said extract of said tissue or said body fluid with insoluble carrier chemically coupled to soybean trypsin inhibitor and then with insoluble carrier chemically coupled to bovine lung trypsin inhibitor.
Claim 2
Independent Claim
135 words
A method for isolating and purifying kallikrein contained in mammalian tissue or body fluid which comprises contacting an extract of said tissue or said body fluid with a material formed of an insoluble carrier chemically coupled to a proteolytic enzyme inhibitor for kallekrein, said material being selected from an insolubilized naturally occurring enzyme inhibitor so as to bind said kallikrein and eluting said kallikrein therefrom using first 0.1 M acetate buffer of pH 4.0 and second 0.1 N acetic acid solution and immediately adding the eluate drop-wise to 2M Tris-amino-methane HCl buffer of pH 8.0 to 10.0, wherein said process is carried out by contacting said extract of said tissue or said body fluid with insoluble carrier chemically coupled to soybean trypsin inhibitor and then with insoluble carrier chemically coupled to bovine lung trypsin inhibitor.
Claim 3
Dependent Claim
51 words
The method of claim 1 wherein said insoluble carrier and enzyme inhibitor are bonded through an iminocarbonate ester group, a carbamic acid ester group, a pseudourea linkage, an alkyl amino group, a carbonyl alkyl group, an amino group, the tyrosine moiety of protein, the histidine of protein or a carboxyl group.
Claim 4
Dependent Claim
24 words
The method of claim 1 wherein said insolubilized enzyme inhibitor comprises said enzyme inhibitor chemically bound to an insoluble agarose, dextran or polyacrylamide carrier.
Claim 5
Dependent Claim
13 words
The method of claim 1 including concentrating said kallikrein and recovering said kallikrein.
References Cited (Backward Citations)
DE2363201A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1980-06-20 | 1980-12-20 | 1981-06-21 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1984-06-20 | 1984-12-20 | 1985-06-21 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1988-06-20 | 1988-12-20 | 1989-06-21 | $7700.00 | Window Closed / Lapsed |